Using a cognitive app to assess brain tumor patients' quality of life
Official title: Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
Run by Baptist Health South Florida · NCT05504681 · Data updated 2026-11-12
This study tests whether a brain health app can help doctors understand the quality of life and cognitive function of adults treated for brain tumors at the Miami Cancer Institute.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Baptist Health South Florida Academic / other |
| Locations | 1 site (Miami, Florida) |
| Status | Recruiting |
| Started | November 30, 2021 |
| Main results expected | April 2030 |
| Study ends | April 2032 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT05504681 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult patients (18+) with central nervous system tumors who are undergoing treatment and have a life expectancy of at least six months.
✕Probably not a fit
Patients receiving radiotherapy for functional diseases or those who are under 18, pregnant, or incarcerated may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry study aims to evaluate the feasibility of using the Brainlab Cognition app in a neuro-oncology clinic to assess neurocognitive function among patients with central nervous system tumors. It will also explore the integration of electronically reported quality of life parameters into clinical practice. The study will involve adult patients treated for brain tumors at the Miami Cancer Institute, focusing on their experiences and outcomes post-treatment. Data will be collected prospectively to inform future clinical applications.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of neurocognitive function and quality of life in brain tumor patients, leading to improved patient care.
How similar studies have gone: While the integration of cognitive assessments in clinical settings is being explored, this specific approach using the Brainlab Cognition app is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI) 2. Life expectancy ≥ 6 months 3. Willingness to participate in ongoing registration study Exclusion Criteria: 1. Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.) 2. Pediatric patients (\<18 years old), pregnant women, and prisoners.
Where it's running
-
Miami Cancer Institute
Miami, Florida, United States Recruiting
Study contacts
- Principal investigator: Rupesh R Kotecha, MD — Miami Cancer Institute
- Study coordinator: Rupesh R Kotecha
- Email: rupeshk@baptisthealth.net
- Phone: 17865962000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive brain stimulation plus computer-based memory training for mild cognitive impairment
This trial will test whether a short course of non-invasive brain stimulation combined with one of two computer-based brain-training programs helps people aged 60–85 with mild cognitive impairment improve memory, thinking, mood, and daily function.
-
Developing and testing the Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
This project will test a short questionnaire called LiCCoS to see if it can spot thinking and everyday mental problems in adults with liver cirrhosis.
-
Carotid artery wall viscosity and memory problems in older adults
This project will test whether the viscous behavior of the carotid artery wall is linked to memory problems in people over 70 with memory complaints, Alzheimer's disease, or vascular dementia.
-
NeuroFirst brain protection for adults having heart bypass surgery
This trial tests whether a bundled anesthesia approach called NeuroFirst can help people aged 60 and older having planned heart surgery with cardiopulmonary bypass avoid silent brain infarcts and thinking or memory problems after surgery.
-
Nutrition-based interventions to prevent cognitive decline
This study is testing if a 6-month nutrition program can help adults at higher risk for dementia keep their thinking skills sharp.
-
Oral midazolam to help deliver care for older adults with neurocognitive disorders who refuse care
This study will try a short-acting oral midazolam to help nurses and caregivers give essential care to older adults with moderate to severe neurocognitive disorders who resist or refuse care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.